drugset / Trial / NCT01933282
MESA Treatment for NK/T Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
Study on the efficacy and safety of MESA chemotherapy for treating NK/T cell lymphoma
Timeline
- Start
- 2013-01
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 20 mg/m2 | Other |
| Subject | Etoposide | Small molecule | 100 mg/m2 | Other |
| Subject | Methotrexate | Small molecule | 2000 mg/m2 | Intravenous |
| Subject | Polyehylene glycol-asparaginase | Unknown | 2500 unknown | Intramuscular |